Novartis AG EBITDA Margin 2010-2025 | NVS

Novartis AG ebitda margin for the quarter ending March 31, 2025 was 35.12%.

  • Novartis AG average ebitda margin for 2024 was 31.36%, a 1.6% increase from 2023.
  • Novartis AG average ebitda margin for 2023 was 31.87%, a 9.67% decline from 2022.
  • Novartis AG average ebitda margin for 2022 was 29.06%, a 9.83% increase from 2021.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

Novartis AG EBITDA Margin 2010-2025 | NVS

  • Novartis AG average ebitda margin for 2024 was 31.36%, a 1.6% increase from 2023.
  • Novartis AG average ebitda margin for 2023 was 31.87%, a 9.67% decline from 2022.
  • Novartis AG average ebitda margin for 2022 was 29.06%, a 9.83% increase from 2021.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.